Cargando…

Using an Improved Residual Network to Identify PIK3CA Mutation Status in Breast Cancer on Ultrasound Image

BACKGROUND: The detection of phosphatidylinositol-3 kinase catalytic alpha (PIK3CA) gene mutations in breast cancer is a key step to design personalizing an optimal treatment strategy. Traditional genetic testing methods are invasive and time-consuming. It is urgent to find a non-invasive method to...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Wen-Qian, Guo, Yanhui, Ru, Wan-Er, Li, Cheukfai, Zhang, Guo-Chun, Liao, Ning, Du, Guo-Qing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9204315/
https://www.ncbi.nlm.nih.gov/pubmed/35719907
http://dx.doi.org/10.3389/fonc.2022.850515
_version_ 1784728897907064832
author Shen, Wen-Qian
Guo, Yanhui
Ru, Wan-Er
Li, Cheukfai
Zhang, Guo-Chun
Liao, Ning
Du, Guo-Qing
author_facet Shen, Wen-Qian
Guo, Yanhui
Ru, Wan-Er
Li, Cheukfai
Zhang, Guo-Chun
Liao, Ning
Du, Guo-Qing
author_sort Shen, Wen-Qian
collection PubMed
description BACKGROUND: The detection of phosphatidylinositol-3 kinase catalytic alpha (PIK3CA) gene mutations in breast cancer is a key step to design personalizing an optimal treatment strategy. Traditional genetic testing methods are invasive and time-consuming. It is urgent to find a non-invasive method to estimate the PIK3CA mutation status. Ultrasound (US), one of the most common methods for breast cancer screening, has the advantages of being non-invasive, fast imaging, and inexpensive. In this study, we propose to develop a deep convolutional neural network (DCNN) to identify PIK3CA mutations in breast cancer based on US images. MATERIALS AND METHODS: We retrospectively collected 312 patients with pathologically confirmed breast cancer who underwent genetic testing. All US images (n=800) of breast cancer patients were collected and divided into the training set (n=600) and test set (n=200). A DCNN-Improved Residual Network (ImResNet) was designed to identify the PIK3CA mutations. We also compared the ImResNet model with the original ResNet50 model, classical machine learning models, and other deep learning models. RESULTS: The proposed ImResNet model has the ability to identify PIK3CA mutations in breast cancer based on US images. Notably, our ImResNet model outperforms the original ResNet50, DenseNet201, Xception, MobileNetv2, and two machine learning models (SVM and KNN), with an average area under the curve (AUC) of 0.775. Moreover, the overall accuracy, average precision, recall rate, and F1-score of the ImResNet model achieved 74.50%, 74.17%, 73.35%, and 73.76%, respectively. All of these measures were significantly higher than other models. CONCLUSION: The ImResNet model gives an encouraging performance in predicting PIK3CA mutations based on breast US images, providing a new method for noninvasive gene prediction. In addition, this model could provide the basis for clinical adjustments and precision treatment.
format Online
Article
Text
id pubmed-9204315
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-92043152022-06-18 Using an Improved Residual Network to Identify PIK3CA Mutation Status in Breast Cancer on Ultrasound Image Shen, Wen-Qian Guo, Yanhui Ru, Wan-Er Li, Cheukfai Zhang, Guo-Chun Liao, Ning Du, Guo-Qing Front Oncol Oncology BACKGROUND: The detection of phosphatidylinositol-3 kinase catalytic alpha (PIK3CA) gene mutations in breast cancer is a key step to design personalizing an optimal treatment strategy. Traditional genetic testing methods are invasive and time-consuming. It is urgent to find a non-invasive method to estimate the PIK3CA mutation status. Ultrasound (US), one of the most common methods for breast cancer screening, has the advantages of being non-invasive, fast imaging, and inexpensive. In this study, we propose to develop a deep convolutional neural network (DCNN) to identify PIK3CA mutations in breast cancer based on US images. MATERIALS AND METHODS: We retrospectively collected 312 patients with pathologically confirmed breast cancer who underwent genetic testing. All US images (n=800) of breast cancer patients were collected and divided into the training set (n=600) and test set (n=200). A DCNN-Improved Residual Network (ImResNet) was designed to identify the PIK3CA mutations. We also compared the ImResNet model with the original ResNet50 model, classical machine learning models, and other deep learning models. RESULTS: The proposed ImResNet model has the ability to identify PIK3CA mutations in breast cancer based on US images. Notably, our ImResNet model outperforms the original ResNet50, DenseNet201, Xception, MobileNetv2, and two machine learning models (SVM and KNN), with an average area under the curve (AUC) of 0.775. Moreover, the overall accuracy, average precision, recall rate, and F1-score of the ImResNet model achieved 74.50%, 74.17%, 73.35%, and 73.76%, respectively. All of these measures were significantly higher than other models. CONCLUSION: The ImResNet model gives an encouraging performance in predicting PIK3CA mutations based on breast US images, providing a new method for noninvasive gene prediction. In addition, this model could provide the basis for clinical adjustments and precision treatment. Frontiers Media S.A. 2022-05-26 /pmc/articles/PMC9204315/ /pubmed/35719907 http://dx.doi.org/10.3389/fonc.2022.850515 Text en Copyright © 2022 Shen, Guo, Ru, Li, Zhang, Liao and Du https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Shen, Wen-Qian
Guo, Yanhui
Ru, Wan-Er
Li, Cheukfai
Zhang, Guo-Chun
Liao, Ning
Du, Guo-Qing
Using an Improved Residual Network to Identify PIK3CA Mutation Status in Breast Cancer on Ultrasound Image
title Using an Improved Residual Network to Identify PIK3CA Mutation Status in Breast Cancer on Ultrasound Image
title_full Using an Improved Residual Network to Identify PIK3CA Mutation Status in Breast Cancer on Ultrasound Image
title_fullStr Using an Improved Residual Network to Identify PIK3CA Mutation Status in Breast Cancer on Ultrasound Image
title_full_unstemmed Using an Improved Residual Network to Identify PIK3CA Mutation Status in Breast Cancer on Ultrasound Image
title_short Using an Improved Residual Network to Identify PIK3CA Mutation Status in Breast Cancer on Ultrasound Image
title_sort using an improved residual network to identify pik3ca mutation status in breast cancer on ultrasound image
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9204315/
https://www.ncbi.nlm.nih.gov/pubmed/35719907
http://dx.doi.org/10.3389/fonc.2022.850515
work_keys_str_mv AT shenwenqian usinganimprovedresidualnetworktoidentifypik3camutationstatusinbreastcanceronultrasoundimage
AT guoyanhui usinganimprovedresidualnetworktoidentifypik3camutationstatusinbreastcanceronultrasoundimage
AT ruwaner usinganimprovedresidualnetworktoidentifypik3camutationstatusinbreastcanceronultrasoundimage
AT licheukfai usinganimprovedresidualnetworktoidentifypik3camutationstatusinbreastcanceronultrasoundimage
AT zhangguochun usinganimprovedresidualnetworktoidentifypik3camutationstatusinbreastcanceronultrasoundimage
AT liaoning usinganimprovedresidualnetworktoidentifypik3camutationstatusinbreastcanceronultrasoundimage
AT duguoqing usinganimprovedresidualnetworktoidentifypik3camutationstatusinbreastcanceronultrasoundimage